Principal Investigator

Sylvain Meloche

Signalling and Cell Growth

Subscribe to the newsletter

After obtaining his Ph.D. in Molecular Pharmacology at the Université de Montréal, in 1988, Sylvain Meloche completed postdoctoral training in immunology at the Montreal Clinical Research Institute, followed by additional postdoctoral training in biochemistry at the Université de Nice, in France.

He began his teaching career in 1992 and established his research activities at the Centre hospitalier de l’Université de Montréal. Principal Investigator in the Signalling and Cell Growth Research Unit, he joined IRIC in 2003. Sylvain Meloche is a Professor in the Department of Pharmacology and Physiology of the Faculty of Medicine at the Université de Montréal.

Principal Investigator, Signalling and Cell Growth Research Unit
High-Throughput Screening Core Facility Scientific direction

Professor, Department of Pharmacology and Physiology, Faculty of Medicine, Université de Montréal

Research unit on signalling and cell growth

Marcelle-Coutu Pavilion, 2306-5

Phone (office)
(514) 343-6966
(514) 343-7780

Signalling and Cell Growth

Sylvain Meloche and his team study the signalling mechanisms that control cell division, the differentiation and survival of normal and cancer cells. The research aims to identify novel therapeutic targets for cancer treatment based on these mechanisms.

Research topics



Awards and distinctions

  • Project Grant - Canadian Institutes of Health Research, 2021

  • Canada Research Chair (tier 1) in Cellular Signaling, 2011-2018

  • Canada Research Chair (tier 1) in Cellular Signaling, 2004-2011

  • Biotechnology of Tomorrow Award, Genesis Awards, 2009

  • National Investigator, The Fonds de recherche du Québec – Santé, 2003-2004

  • Scientist, Medical Research Council of Canada, 1998-2003

  • Joe Doupe Young Investigator Award, Canadian Society for Clinical Investigation, 1995

  • Scholar, Medical Research Council of Canada, 1992-1997

  • See all awards